rubra medicaments ltd (RBM:Mumbai)
rubra medicaments ltd (RBM) Snapshot
|
Open
4.35
|
Previous Close
4.19
|
|
|
Day High
4.35
|
Day Low
4.35
|
|
|
52 Week High
05/13/13 - 4.87
|
52 Week Low
09/14/12 - 1.31
|
|
|
Market Cap
23.8M
|
Average Volume 10 Days
117.1
|
|
|
EPS TTM
-0.31
|
Shares Outstanding
5.5M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
rubra medicaments ltd (RBM) Related Businessweek News
No Related Businessweek News Foundrubra medicaments ltd (RBM) Details
Rubra Medicaments Limited does not have significant operations. Previously, the company engaged in the manufacture and sale of pharmaceutical formulations. It is looking for alternate opportunities. The company is based in Hyderabad, India. As of March 23, 2010, Rubra Medicaments Limited operates as a subsidiary of Rubra Pharmaceuticals Limited.
rubra medicaments ltd (RBM) Key Developments
Rubra Medicaments Ltd. announced unaudited financial results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported loss before interest and exceptional items of INR 0.131 million against INR 0.144 million a year ago. Loss from ordinary activities before tax was INR 0.131 million against INR 0.144 million a year ago. Net loss was INR 0.131 million against INR 0.144 million a year ago. For the nine months, the company reported loss before interest and exceptional items of INR 0.388 million against INR 0.471 million a year ago. Loss from ordinary activities before tax was INR 0.388 million against INR 0.471 million a year ago. Net loss was INR 0.388 million against INR 0.471 million a year ago.
Rubra Medicaments Ltd., Board Meeting, Feb 08, 2013. Agenda: To approve quarterly results.
Rubra Medicaments Ltd. announced unaudited financial results for the second quarter ended September 30, 2012. For the quarter, the company reported loss before interest and exceptional items tax was INR 0.118 million against INR 0.135 million a year ago. Loss before tax was INR 0.118 million against INR 0.135 million a year ago. Net loss was INR 0.118 million against INR 0.135 million a year ago.
| Recently Viewed | |||
| RBM:IN | 4.35 INR | 0.00 |  |
| Company | Last | Change | |
| No competitor information is available for RBM. | |||
| View Industry Companies | |||
Industry Analysis
RBM
Industry Average
| Valuation | RBM | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | -- | Not Meaningful |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact RUBRA MEDICAMENTS LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
